P3 Health Partners Inc. Quarterly report pursuant to Section 13 or 15(d)

Earnings (Loss) per Share (Tables)

9 Months Ended

Sep. 30, 2022


	Successor
	Three Months Ended September 30,		Nine Months Ended September 30,
	2022		2022
Numerator - Basic:
Net loss	$	(65,329,041)	$	(1,029,225,234)
Less: Net loss attributable to Non-controlling interest		(54,155,858)		(853,124,598)
Net loss attributable to Class A common stockholders - Basic		(11,173,183)		(176,100,636)

Numerator - Diluted:
Net loss attributable to Class A Common Stockholders - Basic	$	(11,173,183)	$	(176,100,636)
Add: Net loss and tax effect attributable to Non-controlling interest		(54,155,858)		(853,124,598)
Net loss attributable to Class A common stockholders - Diluted		(65,329,041)		(1,029,225,234)

Denominator - Basic:
Weighted average Class A common shares outstanding - Basic		41,578,890		41,578,890
Loss per share attributable to Class A common shareholders - Basic	$	(0.27)	$	(4.24)

Denominator - Diluted:
Weighted average Class A common shares outstanding - Basic		41,578,890		41,578,890
Weighted average effect of dilutive Class V shares		201,457,191		199,684,102
Weighted average Class A common shares outstanding - Diluted		243,036,081		241,262,992
Loss per share attributable to Class A common shareholders - Diluted	$	(0.27)	$	(4.27)